Accessibility Statement
Eye Pharma S.p.A. is committed to making its website accessible in accordance with the applicable accessibility requirements set out in Italian Legislative Decree No. 82 of 27 May 2022, implementing Directive (EU) 2019/882 – the European Accessibility Act – and in accordance with the applicable technical requirements of UNI CEI EN 301 549.
This accessibility statement applies to the following website:
www.eyepharma.com
Website Owner
Eye Pharma S.p.A.
Via Borghero 9
16148 Genoa (GE), Italy
VAT No. and Tax Code: 01587560994
Compliance Status
Partially compliant
The website www.eyepharma.com is partially compliant with the applicable accessibility requirements of UNI CEI EN 301 549 due to the non-compliance issues listed below.
The identified issues mainly concern text alternatives, colour contrast for certain content and interface elements, the accessibility of some video content, and PDF documents available on the website.
Non-accessible Content
The content listed below is not currently fully accessible.
9.1.1.1 – Non-text Content
Some images and graphical elements on the website do not have an adequate text alternative that communicates their content or function in an equivalent way to users of screen readers or other assistive technologies.
9.1.4.3 – Contrast (Minimum)
In some sections of the website, the visual presentation of text or images of text does not always meet the required minimum contrast ratio against the background, except where specific exemptions provided by the applicable requirements apply.
9.1.4.11 – Non-text Contrast
Some user interface components and informative graphical elements do not always provide sufficient contrast against adjacent colours.
In particular, for certain essential components and their different states, the contrast ratio against adjacent elements may be lower than the 3:1 ratio required by the relevant accessibility requirement.
9.1.2.3 and 9.1.2.5 – Audio Description of Prerecorded Video Content
Some prerecorded video content available on the website does not always provide an equivalent alternative or audio description for significant visual information.
As a result, certain information conveyed exclusively through the visual content of a video may not be fully accessible to users who are unable to perceive the visual content.
Chapter 10 of EN 301 549 – Non-web Documents
Some documents available for download in PDF format are not currently fully accessible.
Depending on the document, they may not include all the structural features required to ensure full use with assistive technologies, such as a proper semantic structure, logical reading order, identification of headings and content, text alternatives for images, and other information required for correct use with screen readers.
Eye Pharma S.p.A. has planned a progressive remediation process for the identified accessibility issues in order to further improve the accessibility of the content and services provided.
No exemption based on disproportionate burden is currently being invoked in relation to the content listed above.
Assessment Method
This statement has been prepared on the basis of a technical accessibility assessment of the website, carried out using a combination of automated and manual checks.
The assessment included:
- automated accessibility analysis and evaluation tools;
- manual checks of pages and key interface components;
- keyboard navigation testing;
- testing with assistive technologies and screen readers;
- checks of the semantic structure of pages and interactive elements;
- verification of the main applicable requirements of UNI CEI EN 301 549 and the Web Content Accessibility Guidelines (WCAG).
The assessment identified the non-compliance issues reported in this statement.
The website is periodically reviewed with the aim of progressively improving its level of accessibility and identifying any new issues resulting from content changes, technological updates or developments to the service.
Preparation of this Accessibility Statement
This statement was prepared on:
1 October 2026
Assessment method: self-assessment carried out through objective technical analysis and manual checks, including testing with assistive technologies.
This statement will be reviewed periodically and whenever substantial changes are made to the website or service.
Reporting Accessibility Issues and Contact Information
Users may report any difficulties in accessing the website’s content or functionalities by contacting:
To help us investigate the issue more effectively, users are encouraged, where possible, to provide:
- the URL of the page or document concerned;
- a brief description of the issue encountered;
- the browser and device used;
- any assistive technology used.
Eye Pharma S.p.A. will review the accessibility reports received in order to identify and, where possible, remove any accessibility barriers.
Reporting to AgID
Where necessary, users may refer to the channels and procedures provided by the Agency for Digital Italy – AgID for reporting accessibility issues relating to digital services.
